drugset / Trial / NCT01280994

Hyperpolarized 129Xe MRI for Imaging Pulmonary Function

NCT01280994 ↗

Phase 2 Recruiting 445 enrolled Bastiaan Driehuys
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to develop and evaluate the usefulness of MRI using 129Xe gas for regional assessment of pulmonary function. Specifically, three forms of 129Xe MRI contrast will be the investigators focus - 1) imaging of the 129Xe ventilation distribution, 2) imaging the alveolar microstructure via the 129Xe apparent diffusion coefficient (ADC), and 3) imaging 129Xe that dissolves in the pulmonary blood and tissues upon inhalation. Such imaging of 129Xe gas transfer is expected to be uniquely sensitive to pathologies affecting gas exchange (fibrosis, emphysema, pulmonary hypertension) and provide new insights regarding the normal resting heterogeneity of pulmonary gas exchange.

Timeline

Start
2011-01
Primary completion
2030-12
Completion
2030-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject 129Xenon Diagnostic / imaging agent — Inhaled